Subtypes of Attention Deficit-Hyperactivity Disorder (ADHD) and Cannabis Use

REFERENCES

• Adler, L., Spencer, T., Faraone, S., Kessler, R., Howes, M., Biederman, J., (2006). Validity of pilot adult ADHD self-report scale (ASRS) to rate adult ADHD symptoms. Annals of Clinical Psychiatry, 18, 145–148.
   PubMedGoogle Scholar
• Adriani, W., Caprioli, A., Granstrem, O., Carli, M., & Laviola, G. (2003). The spontaneously hypertensive-rat as an animal model of ADHD: Evidence for impulsive and non-impulsive subpopulations. Neuroscience and Biobehavioral Reviews, 27, 639–651. doi: 10.1016/j.neubiorev.2003.08.007.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders. (4th ed.). TR. Washington: American Psychiatric Association.
   Google Scholar
• Applegate, B., Lahey, B. B., Hart, E. L., Waldman, I., Biderman, J., Hund, G. W., (1997). Validity of the age of onset criterion for ADHD: A report from the DSM-IV field trials. American Academy of Child & Adolescent Psychiatry, 36, 1211–1221.
   PubMed Web of Science ®Google Scholar
• Biederman, J. (2003). Pharmacotherapy for Attention-Deficit/ Hyperactivity Disorder (ADHD) decreases the risk for substance abuse: Findings from a longitudinal follow-up of youths with and without ADHD. Journal of Clinical Psychiatry, 64, 3–8.
   PubMed Web of Science ®Google Scholar
• Clarke, P. B. S., & Kumar, R. (1983). Characterization of the locomotor stimulant action of nicotine in tolerant rats. British Journal of Pharmacology, 80, 587–594.
   PubMedGoogle Scholar
• Compton, W. M., Grant, B. F., Colliver, J. D., Glantz, M. D., & Stinson, F. S. (2004). Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA, 291, 2114–2121.
   PubMed Web of Science ®Google Scholar
• Devane, W., Dysarz III, F. A., Johnson, R., Melvin, L. S., & Howlett, A.C. (1988). Determination and characterization of a cannabinoid receptor in rat brain. The American Society for Pharmacology and Experimental Therapeutics, 34, 605–613.
   Google Scholar
• Diller, L. H. (1996). The run on Ritalin: Attention deficit disorder and stimulant treatment in the 1990s. Hastings Center Report, 26, 12–18.
   PubMed Web of Science ®Google Scholar
• Fergusson, D. M., & Boden, J. M. (2007). Cannabis use and adult ADHD symptoms. Drug and Alcohol Dependence, 95, 90–96.
   Google Scholar
• Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. F., Dufour, M. C., Compton, W., (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 61, 807–816.
   PubMed Web of Science ®Google Scholar
• Khantzian, E. J. (1974). Opiate addiction: A critique of theory and some implications for treatment. Journal of American Psychotherapy, 28, 59–70.
   PubMed Web of Science ®Google Scholar
• Khantzian, E. J. (1977). The ego, the self, and opiate addiction: Theoretical and treatment considerations. International Review of Psychoanalysis, 5, 189–199.
   Google Scholar
• Kessler, R. C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., (2005). The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychological Medicine, 35, 245–256.
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Adler, L. A., Gruber, M. J., Sarawate, C. A., Spencer, T., & Van Brunt, D. L. (2007). Validity of the world health organization adult ADHD self-report scale (ASRS) screener in a representative sample of health plan members. International Journal of Methods in Psychiatric Research, 16, 52–65.
   PubMed Web of Science ®Google Scholar
• Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011). Prospective association of childhood attention-deficit/ hyperactivity and substance use and abuse/dependence: A meta-analytic review. Clinical Psychology Review, 31, 328–341.
   PubMed Web of Science ®Google Scholar
• Looby, A. (2008). Childhood attention deficit hyperactivity disorder and the development of substance use disorders: Valid concern or exaggeration? Addictive Behaviors, 33, 451–463.
   PubMedGoogle Scholar
• Maxwell, S., & Delaney H. D. (1990). Designing experiments and analyzing data. Belmont: Wadsworth Inc.
   Google Scholar
• Millstein, R. B., Wilens, T. E., Biederman, J., & Spencer, T. J. (1997). Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD. Journal of Attentional Disorders, 2, 159–166.
   Google Scholar
• Murphy, K. R., Barkley, R. A., & Bush, T. (2002). Young adults with attention deficit hyperactivity disorder: Subtype differences in comorbidity, educational, and clinical history. Journal of Nervous and Mental Disorders, 190, 147–157.
   PubMed Web of Science ®Google Scholar
• Navarrete, F., Perez-Ortiz, J. M., & Manzanares, J. (2011). Cannabinoid CB2 receptor-mediated regulation of impulsive-like behavior in DBA/2 mice. British Journal of Pharmacology, 165, 260–273.
   Google Scholar
• Nieoullon, A. (2002). Dopamine and the regulation of cognition and attention. Progress in Neurobiology, 67, 53–83.
   PubMed Web of Science ®Google Scholar
• Pandolfo, P., Pamplona, F. A, Prediger, R. D. S., & Takahashi, R.N. (2007). Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist. European Journal of Pharmacology, 563, 141–148.
   PubMedGoogle Scholar
• Ramtekkar, U., & Mezzacappa, E. (2013). Is ADHD an independent risk factor for cannabis use? A literature review. Comprehensive Psychiatry, 54, e14.
   Google Scholar
• Rounsaville, B. J., Weissman, M. M., Kleber, H., & Wilber, C. (1982). Heterogeneity of psychiatric diagnosis in treated opiate addicts. Archives of General Psychiatry, 39, 161–166.
   PubMed Web of Science ®Google Scholar
• Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S. C. R., Simmons, A., & Bullmore, E. (1999). Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI. American Journal of Psychiatry. 156, 891–896.
   PubMed Web of Science ®Google Scholar
• Russo, E. (2003). Future of cannabis and cannabinoids in therapeutics. Journal of Cannabis Therapeutics, 3, 163–174.
   Google Scholar
• Stinson, F. S., Ruan, W. S., Pickering, R., & Grant, B. F. (2006). Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity. Psychological Medicine, 36, 1447–1460.
   PubMed Web of Science ®Google Scholar
• Strohbeck-Kuehner, P., Skopp, G., & Mattern, R. (2008). Cannabis improves symptoms of ADHD. Cannabinoids, 3, 1–3.
   Google Scholar
• Struve, F. A., Patrick, G., Straumanis, J. J., Fitz-Gerald, M. J., & Manno, J. (1998). Possible EEG sequelae of very long duration marihuana use: Pilot findings from topographic quantitative EEG analyses of subjects with 15 to 24 years of cumulative daily exposure to THC. Clinical Electroencephalography, 29, 31–39.
   PubMedGoogle Scholar
• Struve, F. A., Straumanis, J. J., Patrick, G., Leavitt, J., Manno, J. E., & Manno, B. R. (1999). Topographic quantitative EEG sequelae of chronic marihuana use: A replication using medically and psychiatrically screened normal subjects. Drug and Alcohol Dependence, 56, 167–179.
   PubMed Web of Science ®Google Scholar
• Thiruchelvam, D., Charach, A., Schachar, R. J. (2001). Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 922–928.
   PubMed Web of Science ®Google Scholar
• Tobaiqy, M., Stewart, D., Helms, P., Williams, J., Crum, J., Steer, C., & McLay, J. (2011). Parental reporting of adverse drug reactions associated with Attention Deficit Hyperactivity Disorder (ADHD) medications in children attending specialist pediatric clinics in the UK. Drug Safety, 34, 211–219.
   PubMedGoogle Scholar
• Tzelgov, J., & Henik, A. (1991). Suppression situations in psychological research: Definitions, implications, and applications. Psychological Bulletin, 109, 524–536.
   Web of Science ®Google Scholar
• Weiss, R. D., Griffin, M. L., & Mirin, S. M. (1992). Drug abuse as self-medication for depression: An empirical study. The American Journal of Drug and Alcohol Abuse, 18, 121–129.
   PubMed Web of Science ®Google Scholar
• Wilens, T. E., Adamson, J., Sgambati, S., Whitley, J., Santry, A., Monuteaux, M. C., (2007). Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. The American Journal on Addiction, 16, 14–23.
   PubMed Web of Science ®Google Scholar
• Wilens, T., & Biederman, J. (1993). Psychopathology in preadolescent children at high risk for substance abuse: A review of the literature. Harvard Review of Psychiatry, 1, 207–218.
   PubMed Web of Science ®Google Scholar
• Wilens, T. E. (2006). Mechanisms of action of agents used in attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 67, 32–37.
   PubMed Web of Science ®Google Scholar
• Wilens, T. E., & Dodson, W. (2004). A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. Journal of Clinical Psychiatry, 65, 1301–1313.
   PubMed Web of Science ®Google Scholar
• Zang, Y., Jin, Z., Weng, X., Zhang, L., Zeng, Y., Yang, L., (2004). Functional MRI in attention-deficit hyperactivity disorder: Evidence for hypofrontality. Brain & Development, 27, 544–550.
   Google Scholar